Illumina, Inc. (NASDAQ:ILMN) announced that it will issue results for first quarter 2015 following the close of market on Tuesday, April 21, 2015.
Berry Genomics Co., Ltd.
After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off …
(BUSINESS WIRE)–Mar. 4, 2015– Illumina, Inc.
Illumina, Inc. (NASDAQ:ILMN) announced the launch of the NeoPrep™ Library Prep System, which greatly simplifies library preparation and delivers high-quality sequencing-ready libraries for next-generation …
In a research report sent to investors, William Blair analyst Amanda Murphy maintained an Outperform rating on Illumina (NASDAQ:ILMN), as the company reported fourth-quarter …
BTIG analyst Dane Leone reiterated a Buy rating on Illumina (NASDAQ:ILMN) and raised the price target to $240 (from $220), as the company reported fourth-quarter results and updated 2015 …
(BUSINESS WIRE)–Jan. 27, 2015– Illumina, Inc.
(BUSINESS WIRE)–Jan. 21, 2015– Illumina, Inc.
Illumina (NASDAQ:ILMN) is a biotechnology company based right here in my home town of San Diego. The company manufactures life-science tools for gene …
